Abstract
Methods: Consecutive patients with atrial fibrillation (group AF, 182 patients, age 62±14 years) and prosthetic heart valves (group PV, 82 patients, age 61±15) that presented to our department for routine measurement of INR levels were included in the study. They were on acenocoumarol therapy for at least 6 months. They answered a questionnaire of 9 questions concerning food and drug interactions, knowledge about target INR levels, safety of intramuscular injections and precautions during invasive dental procedures. One point was assigned for each correct answer. Patients were also asked to report if their anticoagulation treatment was supervised by cardiologists or other physician subspecialties.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
